These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25088037)

  • 1. CRIM1, the antagonist of BMPs, is a potential risk factor of cancer.
    Zeng H; Tang L
    Curr Cancer Drug Targets; 2014; 14(7):652-8. PubMed ID: 25088037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface.
    Wilkinson L; Kolle G; Wen D; Piper M; Scott J; Little M
    J Biol Chem; 2003 Sep; 278(36):34181-8. PubMed ID: 12805376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
    Ehata S; Yokoyama Y; Takahashi K; Miyazono K
    Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis?
    Buijs JT; Petersen M; van der Horst G; van der Pluijm G
    Curr Pharm Des; 2010; 16(11):1291-300. PubMed ID: 20166979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRIM1, a newfound cancer-related player, regulates the adhesion and migration of lung cancer cells.
    Zeng H; Zhang Y; Yi Q; Wu Y; Wan R; Tang L
    Growth Factors; 2015; 33(5-6):384-92. PubMed ID: 26653968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crim1KST264/KST264 mice display a disruption of the Crim1 gene resulting in perinatal lethality with defects in multiple organ systems.
    Pennisi DJ; Wilkinson L; Kolle G; Sohaskey ML; Gillinder K; Piper MJ; McAvoy JW; Lovicu FJ; Little MH
    Dev Dyn; 2007 Feb; 236(2):502-11. PubMed ID: 17106887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crim1 is required for maintenance of the ocular lens epithelium.
    Tam OH; Pennisi D; Wilkinson L; Little MH; Wazin F; Wan VL; Lovicu FJ
    Exp Eye Res; 2018 May; 170():58-66. PubMed ID: 29458060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
    Jiramongkolchai P; Owens P; Hong CC
    Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.
    Ye L; Mason MD; Jiang WG
    Front Biosci (Landmark Ed); 2011 Jan; 16(3):865-97. PubMed ID: 21196208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of bone morphogenetic proteins in cancer.
    Davis H; Raja E; Miyazono K; Tsubakihara Y; Moustakas A
    Cytokine Growth Factor Rev; 2016 Feb; 27():81-92. PubMed ID: 26678814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
    Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
    Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crim1 regulates integrin signaling in murine lens development.
    Zhang Y; Fan J; Ho JW; Hu T; Kneeland SC; Fan X; Xi Q; Sellarole MA; de Vries WN; Lu W; Lachke SA; Lang RA; John SW; Maas RL
    Development; 2016 Jan; 143(2):356-66. PubMed ID: 26681494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRIM1 is necessary for coronary vascular endothelial cell development and homeostasis.
    Iyer S; Chhabra Y; Harvey TJ; Wang R; Chiu HS; Smith AG; Thomas WG; Pennisi DJ; Piper M
    J Mol Histol; 2017 Feb; 48(1):53-61. PubMed ID: 27803996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells.
    Ogasawara N; Kudo T; Sato M; Kawasaki Y; Yonezawa S; Takahashi S; Miyagi Y; Natori Y; Sugiyama A
    Biol Pharm Bull; 2018; 41(4):604-611. PubMed ID: 29607933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review).
    Ye L; Bokobza SM; Jiang WG
    Int J Mol Med; 2009 Nov; 24(5):591-7. PubMed ID: 19787192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of epithelial to mesenchymal transition by bone morphogenetic proteins.
    McCormack N; O'Dea S
    Cell Signal; 2013 Dec; 25(12):2856-62. PubMed ID: 24044921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crim1 has cell-autonomous and paracrine roles during embryonic heart development.
    Iyer S; Chou FY; Wang R; Chiu HS; Raju VK; Little MH; Thomas WG; Piper M; Pennisi DJ
    Sci Rep; 2016 Jan; 6():19832. PubMed ID: 26821812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRIM1 haploinsufficiency causes defects in eye development in human and mouse.
    Beleggia F; Li Y; Fan J; Elcioğlu NH; Toker E; Wieland T; Maumenee IH; Akarsu NA; Meitinger T; Strom TM; Lang R; Wollnik B
    Hum Mol Genet; 2015 Apr; 24(8):2267-73. PubMed ID: 25561690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.